BSE filing, BSE: 543594. Summary written from the filing by ALFA Finder's alert engine.
Dipna Pharmachem Ltd: key numbers
- Share price
- ₹3.76
- Market cap
- ₹9.88 Cr
- Revenue (annual)
- ₹129.1 Cr
- Net profit (annual)
- ₹2.63 Cr
- P/E (TTM)
- 3.8×Sector 46.1×
- Promoter holding
- 9.13%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dipna Pharmachem Ltd
All →Dipna Pharmachem Management Change
Dipna Pharmachem appointed Shyam Sundar Lohia as Company Secretary and Compliance Officer effective August 5, 2026. The board approved the appointment at its August 5 meeting.
Dipna Pharmachem Other Announcement
Dipna Pharmachem Ltd has filed its quarterly shareholding pattern for the period ending September 30, 2026, as required under SEBI regulations.
Dipna Pharmachem Other Announcement
Dipna Pharmachem Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI LODR, detailing the distribution of equity shares.
Dipna Pharmachem Q4 FY26 Results: Net Profit ₹0.2 Cr, Down 60.0% YoY
Dipna Pharmachem Ltd reported revenue from operations of ₹2.1 Cr (-86.8% YoY) and net profit of ₹0.2 Cr (-60.0% YoY) for Q4 FY26.
- Key figure
- Net profit ₹0.2 Cr · -60.0% YoY
Dipna Pharmachem Management Change
Dipna Pharmachem appointed two new Independent Directors effective May 11, 2026. Board committees were also reconstituted to enhance governance.
Dipna Pharmachem Board Meeting Date
Dipna Pharmachem scheduled a board meeting for July 1, 2026. The board will review audited half-year and annual financial results.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.